☆ 4.4 Letter

mTOR inhibitors sensitize multiple myeloma cells to venetoclax via IKZF3-and Blimp-1-mediated BCL-2 upregulation

HAEMATOLOGICA (2021)

Get Full Text
Add to Collection

Journal

HAEMATOLOGICA
Volume 106, Issue 11, Pages 3008-3013

Publisher

FERRATA STORTI FOUNDATION
DOI: 10.3324/haematol.2021.278506

Keywords

-

Categories

Hematology

Funding

  1. JSPS
  2. International Myeloma Foundation Japan
  3. Jichi Medical University

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.